SBIR/STTR Research Award

Novel Vaginal Drug Delivery System

Award identifier b4fe67c7073397e46cc93da9f19bb796166c6d807c6a424ee4e87627df93b492Awarding agency Department of Health and Human Services

Award amount

$50,000

Program and phase

SBIR · Phase I

Award year

1993

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Not reported
Recipient company
Biogel Technology
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

TELEPHONE NUMBER: (317) 872-3955 AWARDEE NUMBER: 1 R43 CA62645-01 A novel vaginal drug delivery system is developed for multiple drug delivery across the vaginal membrane. Methods of preparation and optimization of this system are proposed. Various structural parameters of the polymer are varied to achieve the desirable release profile. Drug release experiments are carried out to establish the preferred release profile. Several drugs are studied. One of the ultimate goals of this vaginal delivery system is to be useful in treatment of diseases such as breast cancer and osteoporosis.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.